Civica Rx, Hikma to partner on 14 sterile injectables

Civica Rx, the hospital-owned nonprofit generic drug company, signed a five-year agreement with Hikma Pharmaceuticals to manufacture and supply 14 sterile injectable medications, the two organizations announced July 23. 

Advertisement

The 14 products included in the agreement were not immediately disclosed, but Civica Rx said the medicines are used daily by hospitals in emergency care, surgery, pain management and to treat hypertension. 

Initial shipments of the generic injectables to member hospitals are expected to begin this year. 

Civica Rx was founded in 2018 by several big-name hospital systems to boost the access and affordability of generic drugs. More than 30 health systems representing more than 900 hospitals are Civica Rx members.

More articles on pharmacy:
Oklahoma opioid trial wraps: 10 takeaways
Drugmaker tried to shred records before FDA inspection, agency claims
Publix Pharmacy to deliver prescriptions to patients before hospital discharge

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The Performance Gap Your Pharmacy Training Metrics Can’t See

Monday, August 10
12:00 PM - 1:00 PM CDT

Presenters: Michael Alexander, AudirieDr. Tina Moen, PharmD, Colibri Healthcare

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.